I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
08 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
03 févr. 2020 14h11 HE
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
I-PEN®, I-DROP® et I-PLUG® maintenant offerts en Espagne et au Portugal grâce à un partenariat avec IMEX
08 janv. 2018 09h16 HE
|
I-MED Pharma
MONTRÉAL, 08 janv. 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, a annoncé aujourd’hui la...
I-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEX
08 janv. 2018 09h16 HE
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX...